These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1859 related articles for article (PubMed ID: 23791610)
1. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610 [TBL] [Abstract][Full Text] [Related]
2. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation. Shi L; Shi L; Zhang H; Hu Z; Wang C; Zhang D; Song G Mol Med Rep; 2013 Aug; 8(2):439-45. PubMed ID: 23754536 [TBL] [Abstract][Full Text] [Related]
3. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216 [TBL] [Abstract][Full Text] [Related]
5. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Liu H; Zhong H; Yin Y; Jiang Z Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835 [TBL] [Abstract][Full Text] [Related]
6. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144 [TBL] [Abstract][Full Text] [Related]
7. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats. Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707 [TBL] [Abstract][Full Text] [Related]
8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
9. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME; Garcimartin A; Muñoz-Martínez E Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234 [TBL] [Abstract][Full Text] [Related]
10. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945 [TBL] [Abstract][Full Text] [Related]
11. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
12. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L; Fang K; Dan X; Gu M Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686 [TBL] [Abstract][Full Text] [Related]
13. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
14. Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor α-mediated mechanism in mice. Cui Y; Wang X; Xue J; Liu J; Xie M Nutr Res; 2014 Mar; 34(3):268-75. PubMed ID: 24655494 [TBL] [Abstract][Full Text] [Related]
15. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice. Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698 [TBL] [Abstract][Full Text] [Related]
16. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis. Zhang H; Li Y; Hu J; Shen WJ; Singh M; Hou X; Bittner A; Bittner S; Cortez Y; Tabassum J; Kraemer FB; Azhar S PLoS One; 2015; 10(9):e0138203. PubMed ID: 26394137 [TBL] [Abstract][Full Text] [Related]
17. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. Hu XQ; Wang YM; Wang JF; Xue Y; Li ZJ; Nagao K; Yanagita T; Xue CH Lipids Health Dis; 2010 Mar; 9():25. PubMed ID: 20211032 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats. Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699 [TBL] [Abstract][Full Text] [Related]
19. Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2. Zhao Y; Pan Y; Yang Y; Batey R; Wang J; Li Y J Transl Med; 2015 Jun; 13():174. PubMed ID: 26031670 [TBL] [Abstract][Full Text] [Related]